Needham Reiterates Hold on Collegium Pharmaceutical
Portfolio Pulse from Benzinga Newsdesk
Needham analyst Serge Belanger has reiterated a Hold rating on Collegium Pharmaceutical (NASDAQ:COLL).

August 09, 2024 | 12:12 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Needham analyst Serge Belanger has reiterated a Hold rating on Collegium Pharmaceutical. This suggests that the analyst does not see significant upside or downside potential in the short term.
The reiteration of a Hold rating indicates that the analyst believes the stock is fairly valued at its current price. This typically suggests limited short-term price movement, either up or down.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100